Any advancements in neuroblastoma research are welcome, but these findings are a bit unsettleing for me. To come to the possible conclusion that GCSF, as part of a Standard Protocol in treatment, may be doing more harm than good, adds to the already plentiful "What Ifs" about decisions made regarding Darrel years ago. Of course I know the choices made were the best we could do from the options available at the time, but the lingering doubts that more could have been done never really go away.
Taken from Our Friends at Neuroblastoma Australia:
http://www.medscape.com/viewarticle/845310
